Gut dysbiosis and bile acid (BA)
metabolism disturbance
are involved
in the pathogenesis of ulcerative colitis. This study aimed to investigate
the effect of fucoidan on BA metabolism and gut microbiota in dextran
sulfate sodium-induced colitis mice. Our results showed that fucoidan
effectively suppressed colonic inflammation and repaired the gut barrier.
In addition, fucoidan increased the relative abundance of the Lachnospiraceae
family, such as Turicibacter, Muribaculum, Parasutterella, and Colidextribacter, followed by an increase in short-chain fatty acids, especially
in butyrate. Moreover, fucoidan modulated bile acid metabolism by
elevating cholic acid, ursodeoxycholic acid, deoxycholic acid, and
lithocholic acid and decreasing β-muricholic acid, which led
to activation of FXR and TGR5 and further enhanced the gut barrier
and suppressed colonic inflammation. Our results revealed that the
effect of fucoidan alleviating colitis was largely mediated by gut
microbiota, which was confirmed by the fecal transplantation experiment.
Collectively, these findings provided the basis for fucoidan as a
potential functional food for colitis.